Target intelligence / Profile preview

TNF-alpha production pathway

Molecular classification
Other (Signaling pathway)
01

Overview

The TNF-alpha production pathway describes the sequence of molecular events leading to the transcription, translation, and secretion of tumor necrosis factor alpha (TNF-α), an inflammatory cytokine primarily produced by activated macrophages, T cells, and several other cell types. Induction of TNF-α involves activation of pattern recognition receptors (PRRs) via infection or stress, leading to signal transduction through pathways such as NF-κB and MAPK. These transcription factors upregulate TNF-α mRNA, which is also subject to post-transcriptional regulation affecting stability and translation[3][5]. TNF-α is initially synthesized as a type II transmembrane protein (tmTNF-α) and is cleaved by metalloproteases (e.g., TACE/ADAM17) to release a soluble, biologically active form (sTNF-α)[1][6]. The pathway also incorporates feedback and amplification loops central to inflammatory signaling, immune defense, and disease pathogenesis[5].

Other names
Tumor necrosis factor alpha production pathwayTNF-α biosynthesis pathwayTNF production pathwayTNF-α signaling cascade
02

Mechanism of action

TNF-α neutralization (monoclonal antibodies); TNF receptor antagonism (soluble receptor decoys); Inhibition of upstream signaling (e.g., p38 MAPK, NF-κB inhibitors); Transcriptional or post-transcriptional inhibition of TNF-α biosynthesis

03

Biological functions

Immune responseInflammationApoptosisCell proliferationCell survivalCytokine signaling
04

Disease associations

InflammationAutoimmune diseaseCancerInfectionCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Immunosuppression and increased infection risk due to blockade of inflammatory signalingReactivation of latent tuberculosisRisk of malignancy with prolonged immunosuppressionInjection or infusion reactions
06

Interacting drugs

Infliximab

5 more in the full profile.

07

Biomarkers

TNF-α serum levelsNF-κB activity stateC-reactive protein (CRP; indirect)IL-6 (indirect, as part of inflammatory signature)

Beyond the preview

Go deeper on TNF-alpha production pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TNF-alpha production pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call